SCHEMBL5029665

SCHEMBL5029665

CC(C)N(C(=O)O)[C@]1(C(C)(C)C)CC[C@H](NC(=O)CNC(=O)OCc2ccccc2)[C@H](CO)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 2/20 0.40
TSHR P16473 2/20 0.40
FUCA1 P04066 1/20 0.38
MAPK1 P28482 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM1A O60341 1/20 0.36
RCOR1 Q9UKL0 1/20 0.36
PSMB5 P28074 1/20 0.36
GAA P10253 1/20 0.36
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
CYP2D6 P10635 1/20 0.35
CCR2 P41597 1/20 0.35
KCNH2 Q12809 1/20 0.35
OPRK1 P41145 1/20 0.35
MCHR1 Q99705 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5229279 0.74 ALDH1A1 (0.60) ALDH1A1CYP3A4TSHRFUCA1MAPK1
SCHEMBL5029664 0.74 ALDH1A1 (0.46) ALDH1A1CYP3A4TSHRKDM1ARCOR1
SCHEMBL5029150 0.73 ALDH1A1 (0.55) ALDH1A1CYP3A4TSHRFUCA1MAPK1
SCHEMBL5029161 0.73 ALDH1A1 (0.55) ALDH1A1CYP3A4TSHRFUCA1MAPK1
SCHEMBL18800975 0.69 ALDH1A1 (0.79) ALDH1A1CYP3A4TSHRMAPK1MEN1
SCHEMBL5029290 0.68 ALDH1A1 (0.49) ALDH1A1CYP3A4TSHRMEN1KMT2A
SCHEMBL5029280 0.68 ALDH1A1 (0.49) ALDH1A1CYP3A4TSHRMEN1KMT2A
SCHEMBL5033692 0.68 CCR2 (0.61) ALDH1A1CYP3A4TSHRKDM1ARCOR1
SCHEMBL5033696 0.68 CCR2 (0.61) ALDH1A1CYP3A4TSHRKDM1ARCOR1
SCHEMBL5031889 0.68 ALDH1A1 (0.47) ALDH1A1CYP3A4MEN1KMT2AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378409-B2 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-27 US disclosed
US-20050054626-A1 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054626-A1 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity CCL11, CCR1, CCR2 ALDH1A1 827/4885CYP3A4 3690/4885TSHR 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.